Back

When is percutaneous approach the ideal therapeutic strategy?

11 May 2024 (08:54 - 09:06)
Organised by: Logo
Congress Presentation Part of: Heart failure and coronary artery disease: medicate? dilate? or operate? Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS) HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Mark C Petrie

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Why is CAD underdiagnosed in ADHF patients?
Professor H. Skouri (Beirut, LB)
Slides Video
Presentation thumbnail
Medical treatment or surgical revascularisation in HF of ischaemic aetiology?
Doctor J. Bartunek (Aalst, BE)
Slides Video
Presentation thumbnail
Heart failure and coronary artery disease: medicate? dilate? or operate? - discussion
Video

Access the full session

Session thumbnail
Heart failure and coronary artery disease: medicate? dilate? or operate?
Video

The Event

Event poster

Heart Failure 2024

11 May 2024 08:54 CET
You may be interested in
thumbnail
Congress Presentation
Heart failure and coronary artery disease: medicate? dilate? or operate? - discussion
thumbnail
Congress Session
Heart failure and coronary artery disease: medicate? dilate? or operate?
thumbnail
Congress Session
Clinical Case Management: revascularisation in heart failure when and how?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources